Sarepta Therapeutics, Inc.SRPTNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$24.08
Net Income/Share$-2.71
Operating CF/Share$-2.44
Free CF/Share$-3.88
Cash/Share$8.49
Book Value/Share$13.17
Tangible Book/Share$12.87
Equity/Share$13.17
Interest Debt/Share$12.69
CapEx/Share$1.44
Dividend/Share$0.00
Valuation
Market Cap$2.13B
Enterprise Value$2.77B
P/E Ratio-7.51P/S Ratio0.88P/OCF Ratio-8.33
P/FCF Ratio-5.48
P/B Ratio1.54P/TB Ratio1.54
EV/Sales1.15EV/EBITDA-15.32
Graham Valuation
Graham Number--
Graham Net-Net$-3.77
Profitability
Earnings Yield-13.32%FCF Yield-18.24%ROE-20.31%ROIC-4.92%Return on Tangible Assets-7.84%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-58.94%
CapEx/Revenue5.97%
CapEx/Depreciation2.90
SBC/Revenue5.93%
SG&A/Revenue21.85%
R&D/Revenue57.86%
Liquidity & Solvency
Debt/Equity0.95Debt/Assets0.36Debt/Market Cap0.59
Net Debt/EBITDA-3.53
Current Ratio2.95Interest Coverage-5.81xIncome Quality0.90Efficiency
Days Sales Outstanding82 days
Days Payables Outstanding60 days
Days Inventory686 days
Receivables Turnover4.46x
Payables Turnover6.10x
Inventory Turnover0.53x
Capital Structure
Tangible Assets$1.29B
Working Capital$1.80B
Invested Capital$2.33B
Intangibles/Assets0.85%